|Title||Cooperative development of antimicrobials: looking back to look ahead.|
|Publication Type||Journal Article|
|Year of Publication||2015|
|Journal||Nat Rev Microbiol|
|Date Published||2015 10|
|Keywords||Anti-Bacterial Agents, Anti-Infective Agents, Antimalarials, Antitubercular Agents, Cooperative Behavior, Drug Discovery, Europe, History, 20th Century, Interinstitutional Relations, Public-Private Sector Partnerships, United States|
As foundations and governments mobilize to tackle antimicrobial resistance (AMR), several experiments in academic-industrial collaboration have emerged. Here, I examine two historical precedents, the Penicillin Project and the Malaria Project of the Second World War, and two contemporary examples, the Tuberculosis Drug Accelerator programme and the Tres Cantos Open Lab. These and related experiments suggest that different strategies can be effective in managing academic-industrial collaborations, and that such joint projects can prosper in both multisite and single-site forms, depending on the specific challenges and goals of each project. The success of these strategies and the crisis of AMR warrant additional investment in similar projects.
|Alternate Journal||Nat. Rev. Microbiol.|